Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Patients classified as likely having primary ciliary dyskinesia (PCD) had bronchiectasis and situs inversus totalis. The number of patients with asthma was higher among those with likely PCD vs.

Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations ...

Neutrophils are the core airway inflammatory cell in bronchiectasis ... and 18.7% a history of asthma. Among the secondary endpoints, time to the first exacerbation was longer with brensocatib ...

Permanent changes such as bronchiectasis may persist. ABPA: Allergic bronchopulmonary aspergillosis; GINA: Global initiative for asthma. Adapted with permission from [7]. ABPA-S Fulfils the ...

phase 3 readouts in COPD in H2 2025 and bronchiectasis in 2026 Amlitelimab: clinically meaningful efficacy in asthmaPreliminary results from the TIDE-Asthma phase 2 study (clinical study ...

Bronchiectasis impacts up to 500,000 Americans, but there is often misdiagnosis or delayed diagnosis as the condition can present similarly to other pulmonary conditions such as COPD or asthma.

Amlitelimab reduced asthma exacerbations by over 70% in biomarker ... Finally, itepekimab is being explored in a phase 2 study in bronchiectasis, with the readout anticipated in 2026.

Itepekimab expanding into chronic rhinosinusitis along with COPD and bronchiectasis ... for amlitelimab in adults with moderate-to-severe asthma. Amlitelimab: clinically meaningful efficacy ...